Related Experiment Videos
[Clinical chemical parameter changes in patients with liver metastases]
Vutreshni Bolesti
|January 1, 1979
Summary
Biochemical tests can indicate liver metastases in abdominal cancers. While abnormal levels of alkaline phosphatase (AP), CE, GOT, GGTP, ESR, and Weltman test suggest liver involvement, they don't replace surgical confirmation.
Area of Science:
- Biochemistry
- Oncology
- Clinical Diagnostics
Context:
- Abdominal cancers present diagnostic challenges, particularly in detecting liver metastases.
- Biochemical markers are frequently used as auxiliary diagnostic tools in oncology.
Purpose:
- To evaluate the utility of specific biochemical serum parameters in identifying liver metastases in patients with abdominal malignancies.
- To compare the diagnostic value of these markers in patients with and without confirmed liver metastases.
Summary:
- Serum levels of AP, CE, GOT, GGTP, ESR, and Weltman test were significantly more abnormal in patients with liver metastases compared to those without.
- Elevated LAP and Regan isoenzyme activity were observed more frequently in patients without liver metastases.
- While biochemical tests can suggest liver metastases, they are not definitive and cannot replace invasive diagnostic procedures like laparoscopy or laparotomy.
Impact:
- This study highlights the potential of a panel of biochemical markers to aid in the early detection of liver metastases.
- Findings suggest that specific combinations of abnormal biochemical parameters may improve diagnostic accuracy for liver involvement in abdominal cancers.
- The research underscores the importance of integrating biochemical data with established diagnostic methods for comprehensive patient assessment.